MedTrace Logo

Reason for Prescribing Rice Infant Formula

NCT06318117 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 41

Last updated 2026-01-30

No results posted yet for this study

Summary

The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.

Conditions

  • Infant Formula

Interventions

OTHER

Rice infant formula

Any commercially available rice infant formula whom the pediatrician has previously deemed, or is deeming it useful to consume.

Sponsors & Collaborators

  • BioFortis

    collaborator OTHER

  • Mead Johnson Nutrition

    lead INDUSTRY

Principal Investigators

  • Hugues Piloquet, MD · CHU Nantes Children's chronic disease service

Eligibility

Min Age
6 Months
Max Age
36 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-03-12
Primary Completion
2025-10-31
Completion
2025-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06318117 on ClinicalTrials.gov